{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:04:24Z","timestamp":1762560264671},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T00:00:00Z","timestamp":1473206400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s40261-016-0461-4","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T00:58:42Z","timestamp":1473209922000},"page":"1-6","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Improving Medication Dosing in the Obese Patient"],"prefix":"10.1007","volume":"37","author":[{"given":"Brian L.","family":"Erstad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,7]]},"reference":[{"key":"461_CR1","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","volume":"311","author":"CL Ogden","year":"2014","unstructured":"Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011\u20132012. JAMA. 2014;311:806\u201314.","journal-title":"JAMA"},{"key":"461_CR2","unstructured":"Centers for Disease Control and Prevention: Data, Trends and Maps. Available online at: http:\/\/www.cdc.gov\/obesity\/data\/prevalence-maps.html . Accessed 13 Jan 2016."},{"key":"461_CR3","unstructured":"Centers for Disease Control and Prevention: NCHS Health E-Stat. Available online at: http:\/\/www.cdc.gov\/nchs\/data\/hestat\/obesity_adult_09_10\/obesity_adult_09_10.htm . Accessed 13 Jan 2016."},{"key":"461_CR4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/03014460500154384","volume":"32","author":"R Godoy","year":"2005","unstructured":"Godoy R, Goodman E, Levins R, Leonard WR. Anthropometric variability in the USA: 1971\u20132002. Ann Hum Biol. 2005;32:469\u201386.","journal-title":"Ann Hum Biol"},{"key":"461_CR5","doi-asserted-by":"crossref","first-page":"w822","DOI":"10.1377\/hlthaff.28.5.w822","volume":"28","author":"EA Finkelstein","year":"2009","unstructured":"Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer and service-specific estimates. Health Aff. 2009;28:w822\u201331.","journal-title":"Health Aff"},{"key":"461_CR6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/obr.12059","volume":"14","author":"E Grieve","year":"2013","unstructured":"Grieve E, Fenwick E, Yang H-C, Lean M. The disproportionate economic burden associated with severe and complicated obesity: a systematic review. Obesity Rev. 2013;14:883\u201394.","journal-title":"Obesity Rev"},{"key":"461_CR7","doi-asserted-by":"crossref","unstructured":"Van Lancker P1, Dillemans B, Bogaert T, Mulier JP, De Kock M, Haspeslagh M. Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients. Anaesthesia 2011;66:721\u20135.","DOI":"10.1111\/j.1365-2044.2011.06782.x"},{"key":"461_CR8","doi-asserted-by":"crossref","unstructured":"van Kralingen S, van de Garde EM, Knibbe CA, Diepstraten J, Wiezer MJ, van Ramshorst B, van Dongen EP. Comparative evaluation of atracurium dosed on ideal body weight vs. total body weight in morbidly obese patients. Br J Clin Pharmacol 2011;71:34\u201340.","DOI":"10.1111\/j.1365-2125.2010.03803.x"},{"key":"461_CR9","doi-asserted-by":"crossref","unstructured":"Ingrande J, Brodsky JB, Lemmens HJ. Lean body weight scalar for the anesthetic induction dose of propofol in morbidly obese subjects. Anesth Analg 2011;113:57\u201362.","DOI":"10.1213\/ANE.0b013e3181f6d9c0"},{"issue":"suppl","key":"461_CR10","first-page":"524S","volume":"64","author":"Bioelectric impedance analysis in body composition measurement","year":"1996","unstructured":"Bioelectric impedance analysis in body composition measurement. National institutes of health technology assessment conference statement. Am J Clin Nutr. 1996;64(suppl):524S\u201332S.","journal-title":"Am J Clin Nutr"},{"key":"461_CR11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/ajcn\/50.2.255","volume":"50","author":"DS Gray","year":"1989","unstructured":"Gray DS, Bray GA, Gemayel N, et al. Effect of obesity on bioelectrical impedance. Am J Clin Nutr. 1989;50:255\u201360.","journal-title":"Am J Clin Nutr"},{"issue":"suppl","key":"461_CR12","doi-asserted-by":"crossref","first-page":"519S","DOI":"10.1093\/ajcn\/64.3.519S","volume":"64","author":"BJ Zarowitz","year":"1996","unstructured":"Zarowitz BJ. Bioelectrical impedance analysis measurements for drug pharmacokinetics. Am J Clin Nutr. 1996;64(suppl):519S\u201323S.","journal-title":"Am J Clin Nutr"},{"key":"461_CR13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.clnu.2011.12.011","volume":"31","author":"R Thibault","year":"2012","unstructured":"Thibault R, Genton L, Pichard C. Body composition: why, when and for who? Clin Nutr. 2012;31:435\u201347.","journal-title":"Clin Nutr"},{"key":"461_CR14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01.mco.0000165013.54696.64","volume":"8","author":"LZ Coppini","year":"2005","unstructured":"Coppini LZ, Waitzberg DL, Campos AC. Limitations and validation of bioelectrical impedance analysis in morbidly obese patients. Curr Opin Clin Nutr Metab Care. 2005;8:329\u201332.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"461_CR15","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/cc13794","volume":"18","author":"S Ismael","year":"2014","unstructured":"Ismael S, Savalle M, Trivin C, Gillaizeau F, D\u2019Auzac C, Faisy C. The consequences of sudden fluid shifts on body composition in critically ill patients. Crit Care. 2014;18:R49.","journal-title":"Crit Care"},{"key":"461_CR16","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2146\/ajhp080200","volume":"66","author":"JA Demirovic","year":"2009","unstructured":"Demirovic JA, Pai AB, Pai MP. Estimation of creatinine clearance in morbidly obese patients. Am J Health-Syst Pharm. 2009;66:642\u20138.","journal-title":"Am J Health-Syst Pharm"},{"key":"461_CR17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2125.2004.02157.x","volume":"58","author":"B Green","year":"2004","unstructured":"Green B, Duffull SB. What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol. 2004;58:119\u201333.","journal-title":"Br J Clin Pharmacol"},{"key":"461_CR18","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/AAC.00174-11","volume":"55","author":"MP Pai","year":"2011","unstructured":"Pai MP, Nafziger AM, Bertino JS. Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients. Antimicrob Agents Chemother. 2011;55:4006\u201311.","journal-title":"Antimicrob Agents Chemother"},{"key":"461_CR19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s002280050524","volume":"54","author":"LA Bauer","year":"1998","unstructured":"Bauer LA, Black DJ, Lill JS. Vancomycin dosing in morbidly obese patients. Eur J Clin Pharmacol. 1998;54:621\u20135.","journal-title":"Eur J Clin Pharmacol"},{"key":"461_CR20","first-page":"39","volume":"962","author":"JK Alexander","year":"1963","unstructured":"Alexander JK, Dennis EW, Smight WG, et al. Blood volume, cardiac output, and distribution of systemic blood flow in obesity. Cardiovasc Res Centr Bull. 1963;962:39\u201344.","journal-title":"Cardiovasc Res Centr Bull"},{"key":"461_CR21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2967\/jnmt.106.035972","volume":"35","author":"TA Manzone","year":"2007","unstructured":"Manzone TA, Dam HQ, Soltis D, Sagar VV. Blood volume analysis: a new technique and new clinical interest reinvigorate a classic study. J Nucl Med Technol. 2007;35:55\u201363.","journal-title":"J Nucl Med Technol"},{"key":"461_CR22","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0272-6386(00)70052-7","volume":"35","author":"P Anastasio","year":"2000","unstructured":"Anastasio P, Spitali L, Frangiosa A, et al. Glomerular filtration in severely overweight normotensive humans. Am J Kidney Dis. 2000;35:1144\u20138.","journal-title":"Am J Kidney Dis"},{"key":"461_CR23","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2215\/CJN.03610413","volume":"9","author":"S Lemoine","year":"2014","unstructured":"Lemoine S, Guebre-Egziabher F, Sens F, et al. Accuracy of GFR estimation in obese patients. Clin J Am Soc Nephrol. 2014;9:720\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"key":"461_CR24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/11599410-000000000-00000","volume":"51","author":"MJ Brill","year":"2012","unstructured":"Brill MJ, Diepstraten J, van Rongen A, et al. Impact of obesity on drug metabolism and elimination in adults and children. Clin Pharmacokinet. 2012;51:277\u2013304.","journal-title":"Clin Pharmacokinet"},{"key":"461_CR25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/11598930-000000000-00000","volume":"51","author":"SC McLeay","year":"2012","unstructured":"McLeay SC, Morrish GA, Kirkpatrick CM, Green B. The relationship between drug clearance and body size. Clin Pharmacokinet. 2012;51:319\u201330.","journal-title":"Clin Pharmacokinet"},{"key":"461_CR26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-pharmtox-010814-124354","volume":"55","author":"CA Knibbe","year":"2015","unstructured":"Knibbe CA, Brill MJ, van Rongen A, Diepstraten J, van der Graaf PH, Danhof M. Drug disposition in obesity: towards evidence-based dosing. Annu Rev Pharmacol Toxicol. 2015;55:149\u201367.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"461_CR27","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1185\/03007995.2010.481203","volume":"26","author":"MA Gibney","year":"2010","unstructured":"Gibney MA, Aree CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26:1519\u201330.","journal-title":"Curr Med Res Opin"},{"key":"461_CR28","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.clinthera.2004.10.007","volume":"26","author":"S Schwartz","year":"2004","unstructured":"Schwartz S, Hassman D, Shelmet J, et al. A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge \u00d7 6\u00a0mm needle versus a 29 gauge \u00d7 12.7\u00a0mm needle in obese patients with diabetes mellitus. Clin Ther. 2004;26:1663\u201378.","journal-title":"Clin Ther"},{"key":"461_CR29","doi-asserted-by":"crossref","first-page":"986","DOI":"10.2337\/diacare.18.7.986","volume":"18","author":"PG Clauson","year":"1995","unstructured":"Clauson PG, Linde B. Absorption of rapid-acting insulin in obese and non-obese NIDDM patients. Diab Care. 1995;18:986\u201391.","journal-title":"Diab Care"},{"key":"461_CR30","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.2337\/dc10-1126","volume":"33","author":"M Gagnon-Auger","year":"2010","unstructured":"Gagnon-Auger M, Du Souich P, Baillargeon JP, et al. Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with Type 2 diabetes. Diab Care. 2010;33:2502\u20137.","journal-title":"Diab Care"},{"key":"461_CR31","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/00000542-199606000-00010","volume":"84","author":"QH Hogan","year":"1996","unstructured":"Hogan QH, Prost R, Kulier A, Taylor ML, Liu S, Mark L. Magnetic resonance imaging of cerebrospinal fluid volume and the influence of body habitus and abdominal pressure. Anesthesiology. 1996;84:1341\u20139.","journal-title":"Anesthesiology"},{"key":"461_CR32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/ALN.0b013e318209a92d","volume":"114","author":"B Carvalho","year":"2011","unstructured":"Carvalho B, Collins J, Drover DR, Ralls LA, Riley ET. ED50 and ED95 of intrathecal bupivacaine in morbidly obese patients undergoing Cesarean delivery. Anesthesiology. 2011;114:529\u201335.","journal-title":"Anesthesiology"},{"key":"461_CR33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/clpt.2011.104","volume":"90","author":"R Jain","year":"2011","unstructured":"Jain R, Chung SM, Jain L, et al. Implications of obesity for drug therapy: limitations and challenges. Clin Pharmacol Ther. 2011;90:77\u201389.","journal-title":"Clin Pharmacol Ther"},{"key":"461_CR34","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.2146\/ajhp100226","volume":"67","author":"KA Jacques","year":"2010","unstructured":"Jacques KA, Erstad BL. Availability of information for dosing injectable medications in underweight or obese patients. Am J Health-Syst Pharm. 2010;67:1948\u201350.","journal-title":"Am J Health-Syst Pharm"},{"key":"461_CR35","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jamapediatrics.2015.132","volume":"169","author":"MW Harskamp-van Ginkel","year":"2015","unstructured":"Harskamp-van Ginkel MW, Hill KD, Becker K, et al. Drug dosing and pharmacokinetics in children with obesity: a systematic review. JAMA Pediatr. 2015;169:678\u201385.","journal-title":"JAMA Pediatr"},{"key":"461_CR36","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.2011.39.9436","volume":"30","author":"JJ Griggs","year":"2012","unstructured":"Griggs JJ, Mangu PB, Anderson H, et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology Practice Guidelines. J Clin Oncol. 2012;30:1553\u201361.","journal-title":"J Clin Oncol"},{"key":"461_CR37","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbmt.2014.01.019","volume":"20","author":"J Bubalo","year":"2014","unstructured":"Bubalo J, Carpenter PA, Majhail N, et al. Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation Practice Guideline Committee. Biol Blood Marrow Transplant. 2014;20:600\u201316.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-016-0461-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-016-0461-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-016-0461-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T07:06:43Z","timestamp":1568358403000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-016-0461-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["461"],"URL":"https:\/\/doi.org\/10.1007\/s40261-016-0461-4","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,7]]}}}